Figure 4

Confirmation of expression values obtained by microarray hybridization with RealTime-PCR values obtained from different samples others than those used for microarray hybridization but with comparable disease course (values are always normalised to quantity of 18S rRNA and presented + std dev, four animals per group) for following genes: A) HMG-CoA Reductase, B) Low density lipoprotein receptor (LDLR), C) Secretory leukocyte protease inhibitor (SLPI), D) MAP1alpha, E) Glycoprotein NMB (GPNMB), F) Downregulated by Activation gene (DORA), G) B cell-activating factor (BAFF), H) CXCL13, I) Myelin-oligodendrocyte-glycoprotein (MOG), J) Lipocalin 2 and K) Interferon-g regulated-factor-1 (IRF-1). The different disease phase were statistically compared using One Way ANOVA analysis of variance (Holm-Sidak method):*:p < 0.05, **: p < 0.01, ***: p < 0.001.